Cargando…
Development of a hydroxyflavone-labelled 4554W peptide probe for monitoring αS aggregation
Parkinson’s is the second most common neurodegenerative disease, with the number of individuals susceptible due to increase as a result of increasing life expectancy and a growing worldwide population. However, despite the number of individuals affected, all current treatments for PD are symptomatic...
Autores principales: | Watt, Kathryn J. C., Meade, Richard M., James, Tony D., Mason, Jody M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326036/ https://www.ncbi.nlm.nih.gov/pubmed/37414785 http://dx.doi.org/10.1038/s41598-023-37655-3 |
Ejemplares similares
-
Library-Derived Peptide Aggregation Modulators of
Parkinson’s Disease Early-Onset α-Synuclein Variants
por: Watt, Kathryn J. C., et al.
Publicado: (2022) -
An uracil-linked hydroxyflavone probe for the recognition of ATP
por: Bojtár, Márton, et al.
Publicado: (2018) -
Anionic lipid vesicles have differential effects on the aggregation of early onset-associated α-synuclein missense mutants
por: Watt, Kathryn J.C., et al.
Publicado: (2022) -
Insights Into Peptide Inhibition of Alpha-Synuclein Aggregation
por: Torpey, James H., et al.
Publicado: (2020) -
Differential roles of 3-Hydroxyflavone and 7-Hydroxyflavone against nicotine-induced oxidative stress in rat renal proximal tubule cells
por: Sengupta, Bidisha, et al.
Publicado: (2017)